These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 18784091)
1. Long-term follow-up after tight control of blood pressure in type 2 diabetes. Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091 [TBL] [Abstract][Full Text] [Related]
2. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Estacio RO; Jeffers BW; Gifford N; Schrier RW Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192 [TBL] [Abstract][Full Text] [Related]
3. 10-year follow-up of intensive glucose control in type 2 diabetes. Holman RR; Paul SK; Bethel MA; Matthews DR; Neil HA N Engl J Med; 2008 Oct; 359(15):1577-89. PubMed ID: 18784090 [TBL] [Abstract][Full Text] [Related]
4. Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial. Schiel R; Müller UA; Beltschikow W; Stein G J Diabetes Complications; 2006; 20(5):273-9. PubMed ID: 16949513 [TBL] [Abstract][Full Text] [Related]
5. New treatment guidelines for a patient with diabetes and hypertension. Mogensen CE J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164 [TBL] [Abstract][Full Text] [Related]
6. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993 [TBL] [Abstract][Full Text] [Related]
7. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of home blood pressure measurement in the morning in patients with type 2 diabetes: long-term results of a prospective longitudinal study. Kamoi K; Ito T; Miyakoshi M; Minagawa S Clin Exp Hypertens; 2010 May; 32(3):184-92. PubMed ID: 20504126 [TBL] [Abstract][Full Text] [Related]
9. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Schrier RW; Estacio RO; Mehler PS; Hiatt WR Nat Clin Pract Nephrol; 2007 Aug; 3(8):428-38. PubMed ID: 17653121 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J; J Hypertens; 2010 Jun; 28(6):1141-9. PubMed ID: 20486273 [TBL] [Abstract][Full Text] [Related]
11. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study. Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709 [TBL] [Abstract][Full Text] [Related]
12. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. Almgren T; Wilhelmsen L; Samuelsson O; Himmelmann A; Rosengren A; Andersson OK J Hypertens; 2007 Jun; 25(6):1311-7. PubMed ID: 17563546 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress. Mourad JJ; Le Jeune S J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847 [TBL] [Abstract][Full Text] [Related]
14. Implications of the ADVANCE study for clinical practice. Zannad F J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A; J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849 [TBL] [Abstract][Full Text] [Related]
16. The need for tighter control of cardiovascular risk factors in diabetic patients. Viberti G J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160 [TBL] [Abstract][Full Text] [Related]
17. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10). Wilcox R; Kupfer S; Erdmann E; Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481 [TBL] [Abstract][Full Text] [Related]
18. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
19. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study Group BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337 [TBL] [Abstract][Full Text] [Related]
20. Effect of a multifactorial intervention on mortality in type 2 diabetes. Gaede P; Lund-Andersen H; Parving HH; Pedersen O N Engl J Med; 2008 Feb; 358(6):580-91. PubMed ID: 18256393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]